Point72 Asset Management
VTVT icon

Point72 Asset Management’s vTv Therapeutics VTVT Stock Holding History

Point72 Asset Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Buy
+5,947
New +$206K ﹤0.01% 3496

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management's VTVT Position: Q2 2026 in Review

Point72 Asset Management opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 5,947 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #3496 among its holdings.

45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Point72 Asset Management held 5,947 shares of vTv Therapeutics worth $224K as of Q2 2026.
  • vTv Therapeutics was a new Point72 Asset Management position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #3496 holding.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.